Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113024624A details a novel 8-step synthesis of deoxycholic acid from cholic acid, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN101333554B reveals enzymatic resolution for D-lactic acid. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN115073373A details a high-yield asymmetric synthesis route for (R)-5'-methoxylaudanosine, eliminating genotoxic impurities and reducing costs for muscle relaxant manufacturing.
Novel lipase mutant enables high-purity pregabalin intermediate production with improved activity and supply chain reliability for pharmaceutical manufacturing.
Patent CN113717178A discloses a scalable method for chiral 7-azabicyclo[2.2.1]heptane intermediates, offering improved purity and cost efficiency for oncology drug manufacturing.
Patent CN112939892A reveals a green Ru-catalyzed route for quetiapine intermediates. Achieve high purity and yield with water as the only byproduct for cost-effective API manufacturing.
Novel intramolecular Heck reaction synthesis offers superior anti-fibrosis activity. Streamlined process ensures cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing partners.
Patent CN105001666B details water-soluble NIR dye synthesis. Enhances protein detection stability and offers scalable manufacturing for supply chains.
Patent CN106046024B reveals high-yield Cefpodoxime Proxetil synthesis. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable purity.
Novel non-toxic route for Atorvastatin intermediates avoiding cyanide. High purity 99.6% yield. Cost-effective manufacturing solution for global supply chains.
Patent CN101899044B reveals a greener route for Gemifloxacin main ring synthesis, eliminating hazardous reagents like NaH and ensuring reliable supply chain continuity.
Patent CN116348474B discloses efficient oxazoline sugar synthesis enabling specific peptide modification and complex molecule assembly for pharmaceutical research.
Patent CN102267917B reveals a greener synthesis route for methoxyphenamine hydrochloride, offering cost reduction in API manufacturing and superior supply chain reliability.
Patent CN115894525A reveals a novel cyclization method yielding >99.9% purity intermediates, offering significant cost and supply chain advantages for global pharma manufacturers.
Patent CN113249417B reveals a biocatalytic route for chiral cis-beta-aryl-beta-hydroxy-alpha-amino esters using KRED-Bt, offering high stereoselectivity and industrial scalability.
Patent CN109988183B details an eco-friendly route for cefuroxime acid intermediate DCC, eliminating DMAC and reducing waste for reliable supply.
Novel CN116239593B process for Vericiguat intermediate. High yield, short route, cost-effective manufacturing for global supply chains and procurement.
Discover the novel synthesis of azabicyclo[3.3.0]octane derivatives via patent CN102827063B. A scalable, high-yield route avoiding toxic cobalt catalysts for DDP-4 inhibitor production.
Patent CN101747273B reveals a novel two-step synthesis for Blonanserin intermediates, boosting yield from 17% to 80% and ensuring reliable pharmaceutical intermediates supply.
Advanced synthesis of Meropenem intermediates using allyl protection. Offers cost reduction in antibiotic manufacturing and enhanced supply chain reliability for global pharma partners.